Tissue-Targeted In Vivo Gene Transfer Coupled with Histone Deacetylase Inhibitor Depsipeptide (FK228) Enhances Adenoviral Infection in Rat Renal Cancer Allograft Model Systems

Urology

Volumn 70, Issue 6, 2007, Pages 1230-1236

  Kobayashi, Minoru ^a   Okada, Takashi ^a,b   Murakami, Takashi ^a   Ozawa, Keiya ^a   Kobayashi, Eiji ^a   Morita, Tatsuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DEPSIPEPTIDE; GANCICLOVIR; HISTONE DEACETYLASE INHIBITOR; LUCIFERASE; NITRILOTRIACETATE IRON; ROMIDEPSIN; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CATHETERIZATION; CONTROLLED STUDY; DRUG INHIBITION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; IN VIVO STUDY; KIDNEY ALLOGRAFT; KIDNEY CARCINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL ARTERY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS INFECTION;

ADENOVIRIDAE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BRIDGED COMPOUNDS; CARCINOMA, RENAL CELL; DEPSIPEPTIDES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HISTONE DEACETYLASES; KIDNEY NEOPLASMS; LACTONES; MALE; RATS; RATS, INBRED ACI; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 37349078679     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.09.022     Document Type: Article

References (29)

1. Mulders P., Figlin R., deKernion J.B., et al. Renal cell carcinoma: recent progress and future directions. Cancer Res 57 (1997) 5189-5195
2. Hutson T.E., and Quinn D.I. Cytokine therapy: a standard of care for metastatic renal cell carcinoma?. Clin Genitourin Cancer 4 (2005) 181-186
3. Brody S.L., and Crystal R.G. Adenovirus-mediated in vivo gene transfer. Ann NY Acad Sci 716 (1994) 90-100
4. Morral N., O'Neal W.K., Rice K., et al. Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum Gene Ther 13 (2002) 143-154
5. Chen W.Y., Bailey E.C., McCune S.L., et al. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc Natl Acad Sci USA 94 (1997) 5798-5803
6. Marks P.A., Richon V.M., and Rifkind R.A. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92 (2000) 1210-1216
7. Kitazono M., Goldsmith M.E., Aikou T., et al. Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228. Cancer Res 61 (2001) 6328-6330
8. Goldsmith M.E., Kitazono M., Fok P., et al. The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells. Clin Cancer Res 9 (2003) 5394-5401
9. Okegawa T., Nutahara K., Pong R.C., et al. Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor. J Urol 174 (2005) 747-752
10. Taura K., Yamamoto Y., Nakajima A., et al. Impact of novel histone deacetylase inhibitors, CHAP31 and FR901228 (FK228), on adenovirus-mediated transgene expression. J Gene Med 6 (2004) 526-536
11. Goldsmith M.E., Aguila A., Steadman K., et al. The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems. Mol Cancer Ther 6 (2007) 496-505
12. Okegawa T., Sayne J.R., Nutahara K., et al. A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells. J Urol 177 (2007) 1148-1156
13. Bergelson J.M., Cunningham J.A., Droguett G., et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275 (1997) 1320-1323
14. Okada S., Hamazaki S., Ebina Y., et al. Nephrotoxicity and induction of the renal adenocarcinoma by ferric-nitrilotriacetateb (Fe-NTA) in rats. In: Urushizaki I. (Ed). Structure and Function of Iron Storage and Transport Proteins (1983), Elsevier Science, Amsterdam 473-478
15. Okada T., Ramsey W.J., Munir J., et al. Efficient directional cloning of recombinant adenovirus vectors using DNA-protein complex. Nucleic Acids Res 26 (1998) 1947-1950
16. Kita Y., Li X.K., Ohba M., et al. Adenoviral vectors containing the CTLA4IG-gene inhibit chronic rejection in heterotopically transplanted rat tracheas. Transplant Proc 32 (2000) 2036-2037
17. Takahashi M., Hakamata Y., Takeuchi K., et al. Effects of different fixatives on beta-galactosidase activity. J Histochem Cytochem 51 (2003) 553-554
18. Fujishiro J., Takeda S., Takeno Y., et al. Gene transfer to the rat kidney in vivo and ex vivo using an adenovirus vector: factors influencing transgene expression. Nephrol Dial Transplant 20 (2005) 1385-1391
19. Worgall S., Wolff G., Falck-Pedersen E., et al. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 8 (1997) 37-44
20. Haviv Y.S., Blackwell J.L., Kanerva A., et al. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res 62 (2002) 4273-4281
21. Colombo B.M., Benedetti S., Ottolenghi S., et al. The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 6 (1995) 763-772
22. Kim H.R., Kim E.J., Yang S.H., et al. Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway?. Exp Mol Med 38 (2006) 616-624
23. Vanoosten R.L., Moore J.M., Ludig A.T., et al. Depsipeptide (FR901228) enhances the cyctotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts. Mol Ther 11 (2005) 542-552
24. Sandor V., Bakke S.W., Robey R.W., et al. Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin Cancer Res 8 (2002) 718-728
25. Stadler W.M., Margolin K., Ferber S., et al. A phase II study of depsipeptide (FR901228) in refractory metastatic renal cell cancer. Clin Genitourin Cancer 5 (2006) 57-60
26. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 17 (1999) 2244-2245
27. Okimoto T., Yahata H., Itou H., et al. Safety and growth suppressive effect of intra-hepatic arterial injection of AdCMV-p53 combined with CDDP to rat liver metastatic tumors. J Exp Clin Cancer Res 22 (2003) 399-406
28. Sachs M.D., Ramamurthy M., Poel H., et al. Histone deacetylase inhibitors upregulate expression of the Coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells. Cancer Gene Ther 11 (2004) 477-486
29. Pulkkanen K.J., Parkkinen J.J., Laukkanen J.M., et al. HSV-tk gene therapy for human renal cell carcinoma in nude mice. Cancer Gene Ther 8 (2001) 529-536